Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Acute Renal Failure

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43889   clinical trials with a EudraCT protocol, of which   7298   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    565 result(s) found for: Acute Renal Failure. Displaying page 1 of 29.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2008-002077-12 Sponsor Protocol Number: MR-2008/001 Start Date*: 2008-09-24
    Sponsor Name:AZIENDA OSPEDALIERA DI PERUGIA
    Full Title: “Fenoldopam end Renal failure” (FENO-HSR)
    Medical condition: Renal failure from ipoperfusion post Cardiac surgery
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038359 - Renal and urinary disorders 10000821 Acute kidney failure LLT
    14.1 10038359 - Renal and urinary disorders 10048988 Renal artery occlusion PT
    14.1 10047065 - Vascular disorders 10002482 Angiosclerosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004361-12 Sponsor Protocol Number: FER-CIT-2016-01 Start Date*: 2017-03-27
    Sponsor Name:Fernando Sánchez
    Full Title: Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies. Effect of two anticoagulation strategies of ...
    Medical condition: Acute renal failure (ARF).
    Disease: Version SOC Term Classification Code Term Level
    19.1 10042613 - Surgical and medical procedures 10074746 Renal replacement therapy PT
    19.1 100000004857 10038436 Renal failure acute LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-007132-25 Sponsor Protocol Number: AS-CD-04 Start Date*: Information not available in EudraCT
    Sponsor Name:EBI Anti Sepsis B.V.
    Full Title: A randomized, double blind, parallel, placebo controlled, exploratory study to assess the effect of EA-230 on renal function and on safety and tolerability in patients at increased risk of developi...
    Medical condition: acute renal failure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001041 Acute renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-002109-32 Sponsor Protocol Number: CORL2007 Start Date*: 2007-05-10
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
    Full Title: USE OF FENOLDOPAM TO IMPROVE GLOMERULAR FILTRATION RATE IN EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION
    Medical condition: Adult liver transplanted patients age > 18 years , with pre-transplantation normal renal function creatinine clearance 1ml/kg/min
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038436 Renal failure acute LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-018553-35 Sponsor Protocol Number: SMF1482 Start Date*: 2010-05-03
    Sponsor Name:Gambro Lundia AB
    Full Title: SMARTCIT - A NOVEL CITRATE BASED ANTICOAGULATION
    Medical condition: Acute renal failure
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004857 10001041 Acute renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004426-24 Sponsor Protocol Number: 951/07 Start Date*: 2007-07-06
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: PROSTACYCLIJN VERSUS HEPARIN AS ANTICOAGULANT IN CONTINUOUS VENO-VENOUS HEMODIAFILTRATION
    Medical condition: Acute renale failure in intensive unit
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038436 Renal failure acute LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014562-26 Sponsor Protocol Number: CERL080AES08 Start Date*: 2010-02-17
    Sponsor Name:Novartis Farmacéuitica S.A
    Full Title: “Estudio multicéntrico, aleatorizado, abierto de maximización de micofenolato sódico (MFS) versus micofenolato mofetilo (MMF) para minimizar la dosis de tacrolimus en pacientes trasplantados renale...
    Medical condition: Profilaxis del rechazo agudo en trasplante alogénico renal. Minimizar la dosis de tacrolimus en pacientes trasplantados renales en mantenimiento
    Disease: Version SOC Term Classification Code Term Level
    9 10000952 Acute on chronic renal failure LLT
    9 10001041 Acute renal failure LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-001407-11 Sponsor Protocol Number: Certican MHH PRTx01 Start Date*: 2006-07-18
    Sponsor Name:Medizinische Hochschule Hannover
    Full Title: A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolon and switch to low-dose ciclosporine A and everolimus without steroids in the prevent...
    Medical condition: Kidney transplantation after end stage renal failure
    Disease: Version SOC Term Classification Code Term Level
    9.0 10014647 LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006014-20 Sponsor Protocol Number: FARM6X822T Start Date*: 2009-01-19
    Sponsor Name:CONSORZIO MARIO NEGRI SUD
    Full Title: Effects of the dose of erythropoiesis stimulating agents on cardiac-cerebrovascular outcomes and quality of life in hemodialysis patients. The DOSe of Erythropoietins (DOSE) trial.
    Medical condition: End stage kidney disease and anemia, treated with hemodialysis for renal replacement therapy
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014647 End stage renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016801-40 Sponsor Protocol Number: IP-001-09 Start Date*: 2016-01-26
    Sponsor Name:IPERBOREAL PHARMA
    Full Title: Efficacy and Safety assessments of a peritoneal dialysis solution containing Glucose, Xylitol and L-Carnitine compared to standard PD solutions in Continuous Ambulatory Peritoneal Dialysis (CAPD)
    Medical condition: Patients with ESRD treated by CAPD
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038444 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-003866-16 Sponsor Protocol Number: AP REN 01-01 Start Date*: 2009-03-03
    Sponsor Name:AM-Pharma B.V.
    Full Title: A Phase-II, double-blind, randomized, placebo-controlled proof of concept study on the safety and early efficacy of Alkaline Phosphatase in sepsis patients with Renal Failure.
    Medical condition: Sepsis with Renal Failure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10040050 Sepsis NOS LLT
    9.1 10038435 Renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2004-000304-41 Sponsor Protocol Number: FG-506E-12-03 Start Date*: 2004-12-15
    Sponsor Name:Astellas Pharma GmbH
    Full Title: A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMB...
    Medical condition: Patients with end stage kidney disease who will undergo renal transplantation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10014646 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed) SE (Completed) HU (Completed) FI (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2011-000644-16 Sponsor Protocol Number: Dor1.0 Start Date*: 2011-05-03
    Sponsor Name:University of Tartu, Clinic of Anaesthesiology and Intensive Care
    Full Title: High volume haemodiafiltration in treatment of severe sepsis -- impact on pharmacokinetics of doripenem and piperacillin tazobactam and inflammatory response
    Medical condition: adult intensive care patient with severe sepsis or septic shock and acute renal failure requiring renal replacement therapy
    Disease: Version SOC Term Classification Code Term Level
    13.1 10021881 - Infections and infestations 10040047 Sepsis PT
    13.1 10038359 - Renal and urinary disorders 10001041 Acute renal failure LLT
    13.1 10021881 - Infections and infestations 10053879 Sepsis syndrome PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: EE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022584-35 Sponsor Protocol Number: TUD-BRIDGE-046 Start Date*: 2011-11-25
    Sponsor Name:Dresden Universtity of Technology
    Full Title: Clofarabine salvage therapy in patients with relapsed or refractory AML The BRIDGE Trial
    Medical condition: Patients with AML >40 years of age with untreated relapse or refractory disease after a minimum of one standard induction therapy.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10060557 Acute myelocytic leukemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-000520-32 Sponsor Protocol Number: FG-506-02-42 Start Date*: 2005-01-26
    Sponsor Name:Fujisawa GmbH
    Full Title: A MULTICENTRE, RANDOMISED, OPEN CLINICAL STUDY TO COMPARE THE EFFICACY AND SAFETY OF A COMBINATION OF TACROLIMUS AND MYCOPHENOLATE MOFETIL BASED REGIMEN WITH OR WITHOUT INDUCTION IN ELDERLY RECIPIE...
    Medical condition: Patients with end stage kidney disease who will undergo primary renal transplantion or retransplantation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10014646 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2021-006515-28 Sponsor Protocol Number: ASST_FARM_2021TMO_FT14 Start Date*: 2022-06-07
    Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA
    Full Title: Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell Transplantation (allo-SCT) in Acute Myeloid Leukemia (AML...
    Medical condition: Acute Myeloid Leukemia (AML) patients (=40 <65years)
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10000880 Acute myeloid leukaemia PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015114-22 Sponsor Protocol Number: ML22916 Start Date*: 2010-08-10
    Sponsor Name:Roche Pharma AG
    Full Title: A randomized controlled, single-blind, proof- of- concept-study to investigate the protective effects of early treatment with C.E.R.A. in patients with chronic kidney disease on renal disease progr...
    Medical condition: diabetic and transplanted CKD stage III patients
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004857 10064848 Chronic kidney disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-004152-10 Sponsor Protocol Number: EMPATHY Start Date*: 2020-01-30
    Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
    Full Title: Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF S...
    Medical condition: Obesity Renal chronic disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10027433 - Metabolism and nutrition disorders 10029883 Obesity PT
    21.1 100000004857 10009119 Chronic renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-003968-22 Sponsor Protocol Number: ETFLCHD01 Start Date*: 2008-02-04
    Sponsor Name:University Hospital Birmingham
    Full Title: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy
    Medical condition: Multiple myeloma patients with acute dialysis dependent renal failure resulting from cast nephropathy.
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10028566 Myeloma LLT
    14.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10028569 Myelomatosis multiple LLT
    14.0 10038359 - Renal and urinary disorders 10038436 Renal failure acute PT
    14.0 10042613 - Surgical and medical procedures 10018875 Haemodialysis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004888-41 Sponsor Protocol Number: IPeRStudy Start Date*: 2012-12-28
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Intensive Phosphate Control in Development of Renal End Points and Mortality in CKD (the IPeR Study)
    Medical condition: Patients with Chronic Kidney Disease (CKD) not yet on dialysis
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004857 10064848 Chronic kidney disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 24 17:06:44 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA